Peter M. Voorhees
Division of Hematology/Oncology
Department of Medicine
University of North Carolina at Chapel Hill
Chapel Hill
USA
Name/email consistency: high
- Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma. Voorhees, P.M., Chen, Q., Kuhn, D.J., Small, G.W., Hunsucker, S.A., Strader, J.S., Corringham, R.E., Zaki, M.H., Nemeth, J.A., Orlowski, R.Z. Clin. Cancer Res. (2007)